We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
- Authors
Wang, Thomas H; Bhatt, Deepak L; Fox, Keith A A; Steinhubl, Steven R; Brennan, Danielle M; Hacke, Werner; Mak, Koon-Hou; Pearson, Thomas A; Boden, William E; Steg, P Gabriel; Flather, Marcus D; Montalescot, Gilles; Topol, Eric J; CHARISMA Investigators
- Abstract
To examine the unanticipated, excess mortality observed in patients randomized to clopidogrel and aspirin vs. aspirin alone in the prespecified 'asymptomatic' subgroup of CHARISMA, we investigated whether dual-antiplatelet therapy may be associated with adverse cardiovascular (CV) events in a primary prevention population.
- Publication
European heart journal, 2007, Vol 28, Issue 18, p2200
- ISSN
0195-668X
- Publication type
Journal Article
- DOI
10.1093/eurheartj/ehm274